Vanguard Portfolio Management’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
Vanguard Portfolio Management's PRTA Position: Q3 2026 in Review
Vanguard Portfolio Management reduced its Prothena Corp (PRTA) stake by 5% in Q3 2026, selling an estimated $730K and leaving 1,569,525 shares worth $13.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2074.
Vanguard Portfolio Management first reported a position in PRTA in Q1 2026 and has held it in 3 quarters since. The position peaked at $16.2M in Q2 2026. 130 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.
- Vanguard Portfolio Management held 1,569,525 shares of Prothena Corp worth $13.2M as of Q3 2026.
- Vanguard Portfolio Management sold 81,768 Prothena Corp shares in Q3 2026, an estimated $730K.
- Prothena Corp made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #2074 holding.
- Vanguard Portfolio Management first reported a position in Prothena Corp in Q1 2026 and has held it in 3 quarters since.
- Vanguard Portfolio Management's Prothena Corp position peaked at $16.2M in Q2 2026.
- 130 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.